Medical Xpress April 2, 2025
Kayte Spector-Bagdady, The Conversation

As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, concerns about what would happen to the personal information contained in its massive genetic and health information database were swift and widespread. A few days after, a U.S. judge ruled that the company could sell its consumer data as part of the bankruptcy.

The attorneys general of several states warned their citizens to delete their . California urged its citizens to request that 23andMe delete their data and destroy their spit samples. Michigan’s attorney general released a statement warning that “23andMe collects and stores some of the most sensitive personal information, our genetic code.”

When customers originally signed up for 23andMe, they agreed to...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Pharma / Biotech, Precision Medicine, Privacy / Security
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article